Chiron and Xoma to Develop Anticancer Antibodies

By Business Review Editor

Pharma Deals Review: Vol 2004 Issue 46 (Table of Contents)

Published: 4 Apr-2004

DOI: 10.3833/pdr.v2004.i46.814     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

Chiron and Xoma entered into collaborative R&D agreement to develop antibodies for treating cancer...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details